The Research Pharmacy Shared Service (RPSS) is one of the founding core services for this Cancer Center Support grant. It is responsible for investigation cancer drug inventory and preparation for the Multi- disciplinary Clinics of the Arizona Cancer Center. Located in the clinic area of the first floor, the service prepares over 2,800 investigation agents yearly, facilitated through the funding of a pharmacy technician, Estelle Wesau. Robert Dorr, Ph.D., R.Ph. is funded at 10% and serves as director of the services. He oversees the technician and investigational drug logistics for the entire Center. In addition, Dr. Dorr also prepares samples of investigation topical of injectable formulations of new agents or repackages active and placebo dosages for double-blinded pilot clinical trials. The later service totaled six projects for drug formulation and three projects for double-blind repackaging, respectively. The repackaged investigational agents are primarily used in the Cancer Prevention and Control Research Program. The Research Pharmacy Shared Service provides investigational drug reconstitution for daily clinics in the Cancer Center and as such, swerves a variety of peer-reviewed clinical projects including those of the Southwest Oncology Group (SWOG) and the clinical trials of three large translational research program project grants: the Medical Oncology Program Project, the Colon Cancer Prevention Program Project, and the Chemoprevention of Skin Cancer Program Project. Private (drug company) or other investigational trials may use the service of a when-available charge-back basis with funds used to buy equipment (freezers, computer, infusion pumps, etc.) to enhance the overall service effort. However, federal funding for this service is crucial since there are no charges to patients for preparation of any investigational drug, as it is done to pay for pharmacy services with commercially-available drugs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023074-22S2
Application #
6217325
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
22
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Zeltzer, Sebastian; Zeltzer, Carol A; Igarashi, Suzu et al. (2018) Virus Control of Trafficking from Sorting Endosomes. MBio 9:
Nguyen, Mike M; Martinez, Jessica A; Hsu, Chiu-Hsieh et al. (2018) Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort. Eur J Cancer Prev 27:557-562
Jones, Kyle M; Pagel, Mark D; Cárdenas-Rodríguez, Julio (2018) Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI. Magn Reson Imaging 47:16-24
Kohler, Lindsay N; Harris, Robin B; Oren, Eyal et al. (2018) Adherence to Nutrition and Physical Activity Cancer Prevention Guidelines and Development of Colorectal Adenoma. Nutrients 10:
Hornbrook, Mark C; Cobb, Martha D; Tallman, Nancy J et al. (2018) Costs of an ostomy self-management training program for cancer survivors. Psychooncology 27:879-885
Bea, Jennifer W; Funk, Janet; Hetherington-Rauth, Megan et al. (2018) Anthropometry Versus Imaging for Prediction of Inflammation Among Hispanic Girls. Obesity (Silver Spring) 26:1594-1602
Nakamya, Mary F; Ayoola, Moses B; Park, Seongbin et al. (2018) The Role of Cadaverine Synthesis on Pneumococcal Capsule and Protein Expression. Med Sci (Basel) 6:
Loescher, Lois J; Rains, Stephen A; Kramer, Sandra S et al. (2018) A Systematic Review of Interventions to Enhance Healthy Lifestyle Behaviors in Adolescents Delivered via Mobile Phone Text Messaging. Am J Health Promot 32:865-879
Knudsen, Erik S; Balaji, Uthra; Mannakee, Brian et al. (2018) Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 67:508-520
Boese, Cody J; Nye, Jonathan; Buster, Daniel W et al. (2018) Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell 29:2874-2886

Showing the most recent 10 out of 1336 publications